Bonjesta Tablet, Extended Release
Product Images NDC 55494-120

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Bonjesta (NDC 55494-120). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Duchesnay Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bottle Label-outside Front Cover With Imprint Area For Lot & Expiry (Bottle Label 1)

This is a description of a medication called "Bonjesta". It comes in extended-release tablets that contain 20mg of Doxylamine succinate and pyridoxine hydrochloride each. Patients are instructed to swallow the tablet whole, and it should be stored between 20°C to 25°C (68°F to 77°F). The medication is prescribed by a doctor or pharmacist and comes with a patient package insert. The manufacturer is located in Pennsylvania, USA.*

FDA Label Image

Bottle Label – Inside Cover (Bottle Label Inside)

Bonjesta is a medication containing doxylamine succinate and pyridoxine hydrochloride and is available as extended-release tablets. It is important to swallow the tablets whole and not crush, chew, or split them. One package contains 60 extended-release tablets. This medication is used for morning sickness in pregnant women. The usual dosage is not provided in the text. The remaining text appears to be illegible.*

FDA Label Image

Halal Symbol (Halal)

FDA Label Image

Kosher Symbol (Kosher)

FDA Label Image

Structure-1 (Structure 1)

FDA Label Image

Structure-2 (Structure 2)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.